Avelumab in combination with axitinib was found effective and safe as frontline treatment for advanced RCC in real-world ...

I expect it in the ring; but I would have never thought my shoulders would be flat on a hospital bed instead, as I was ...

Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is complex, with diverse therapeutic approaches and their combinations available ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using ...

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...

NSAID use is associated with an increased risk of death from RCC among women but not among men, researchers found.

Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...

According to Laurence Albiges, MD, PhD, treatment of RCC with cabozantinib, nivolumab, and ipilimumab can cause potentially ...

Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based ...

The news comes on the heels of promising Phase I/Ib data, which point to the potential of casdatifan as a more effective ...

Exelixis’ next-generation tyrosine kinase inhibitor zanzalintinib is being tested for colorectal cancer, renal cell carcinoma ...